477 related articles for article (PubMed ID: 1310159)
1. Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma.
Moertel CG; Lefkopoulo M; Lipsitz S; Hahn RG; Klaassen D
N Engl J Med; 1992 Feb; 326(8):519-23. PubMed ID: 1310159
[TBL] [Abstract][Full Text] [Related]
2. Streptozocin alone compared with streptozocin plus fluorouracil in the treatment of advanced islet-cell carcinoma.
Moertel CG; Hanley JA; Johnson LA
N Engl J Med; 1980 Nov; 303(21):1189-94. PubMed ID: 6252466
[TBL] [Abstract][Full Text] [Related]
3. Phase II/III study of doxorubicin with fluorouracil compared with streptozocin with fluorouracil or dacarbazine in the treatment of advanced carcinoid tumors: Eastern Cooperative Oncology Group Study E1281.
Sun W; Lipsitz S; Catalano P; Mailliard JA; Haller DG;
J Clin Oncol; 2005 Aug; 23(22):4897-904. PubMed ID: 16051944
[TBL] [Abstract][Full Text] [Related]
4. Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas.
Kouvaraki MA; Ajani JA; Hoff P; Wolff R; Evans DB; Lozano R; Yao JC
J Clin Oncol; 2004 Dec; 22(23):4762-71. PubMed ID: 15570077
[TBL] [Abstract][Full Text] [Related]
5. The combination of cisplatin, doxorubicin, and mitomycin (PAM) compared with the FAM regimen in treating advanced gastric carcinoma. A phase II randomized trial of the Italian Oncology Group for Clinical Research.
De Lisi V; Cocconi G; Angelini F; Cavicchi F; Di Costanzo F; Gilli G; Rodinò C; Soldani M; Tonato M; Finardi C
Cancer; 1996 Jan; 77(2):245-50. PubMed ID: 8625230
[TBL] [Abstract][Full Text] [Related]
6. A prospective, randomized Phase III trial comparing combination chemotherapy with cyclophosphamide, doxorubicin, and 5-fluorouracil with vinorelbine plus doxorubicin in the treatment of advanced breast carcinoma.
Blajman C; Balbiani L; Block J; Coppola F; Chacon R; Fein L; Bonicatto S; Alvarez A; Schmilovich A; Delgado FM
Cancer; 1999 Mar; 85(5):1091-7. PubMed ID: 10091793
[TBL] [Abstract][Full Text] [Related]
7. Effective treatment of locally advanced endocrine tumors of the pancreas with chemoradiotherapy.
Strosberg J; Hoffe S; Gardner N; Choi J; Kvols L
Neuroendocrinology; 2007; 85(4):216-20. PubMed ID: 17541257
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of 5-FU, doxorubicin, and mitomycin (FAM) and chlorozotocin in advanced measureable pancreatic cancer.
Smith FP; Rustgi VK; Schertz G; Woolley PV; Schein PS
Cancer Treat Rep; 1982 Dec; 66(12):2095-6. PubMed ID: 6215982
[No Abstract] [Full Text] [Related]
9. Prospective randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C for non-resectable pancreatic and biliary carcinoma: multicenter randomized trial.
Takada T; Nimura Y; Katoh H; Nagakawa T; Nakayama T; Matsushiro T; Amano H; Wada K
Hepatogastroenterology; 1998; 45(24):2020-6. PubMed ID: 9951857
[TBL] [Abstract][Full Text] [Related]
10. Failure to confirm major objective antitumor activity for streptozocin and doxorubicin in the treatment of patients with advanced islet cell carcinoma.
de Vries H; Mulder NH; de Vries EG
Cancer; 2000 May; 88(9):2194-5. PubMed ID: 10813734
[No Abstract] [Full Text] [Related]
11. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
[TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy for islet cell carcinoma and metastatic carcinoid tumors with 5-fluorouracil and streptozotocin.
Chernicoff D; Bukowski RM; Groppe CW; Hewlett JS
Cancer Treat Rep; 1979 May; 63(5):795-6. PubMed ID: 222449
[TBL] [Abstract][Full Text] [Related]
13. Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.
Hainsworth JD; Jolivet J; Birch R; Hopkins LG; Greco FA
Cancer; 1997 Feb; 79(4):740-8. PubMed ID: 9024712
[TBL] [Abstract][Full Text] [Related]
14. Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. Gastrointestinal Tumor Study Group.
J Natl Cancer Inst; 1988 Jul; 80(10):751-5. PubMed ID: 2898536
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin versus mitomycin versus doxorubicin plus mitomycin in advanced breast cancer: a randomized study.
Andersson M; Daugaard S; von der Maase H; Mouridsen HT
Cancer Treat Rep; 1986 Oct; 70(10):1181-6. PubMed ID: 3530444
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of chlorozotocin and fluorouracil in islet cell carcinoma: a Southwest Oncology Group study.
Bukowski RM; Tangen C; Lee R; Macdonald JS; Einstein AB; Peterson R; Fleming TR
J Clin Oncol; 1992 Dec; 10(12):1914-8. PubMed ID: 1333517
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
Wadler S; Yeap B; Vogl S; Carbone P
Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
Thigpen T; Vance R; Puneky L; Khansur T
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
[TBL] [Abstract][Full Text] [Related]
19. Phase II trials of maytansine, low-dose chlorozotocin, and high-dose chlorozotocin as single agents against advanced measurable adenocarcinoma of the pancreas. Gastrointestinal Tumor Study Group.
Cancer Treat Rep; 1985 Apr; 69(4):417-20. PubMed ID: 2859924
[TBL] [Abstract][Full Text] [Related]
20. Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer.
Van Hazel G; Blackwell A; Anderson J; Price D; Moroz P; Bower G; Cardaci G; Gray B
J Surg Oncol; 2004 Nov; 88(2):78-85. PubMed ID: 15499601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
